- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 85.06M sh |
| Stock Repurchased | Q1 2025 · Mar 30, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $232.9M |
| Long Term Debt | Q1 2025 · Mar 30, 2025 | $917.61M |
| Long Term Debt | Q1 2025 · Dec 29, 2024 | $1.03B |
| Cash And Equivalents | Q1 2025 · Mar 30, 2025 | $57.69M |
| Cash And Equivalents | Q1 2025 · Dec 29, 2024 | $70.06M |
| Stockholders Equity | Q1 2025 · Mar 30, 2025 | $380.6M |
| Stockholders Equity | Q1 2025 · Dec 29, 2024 | $135.51M |
| Current Liabilities | Q1 2025 · Mar 30, 2025 | $778.47M |
| Current Liabilities | Q1 2025 · Dec 29, 2024 | $952.34M |
| Total Liabilities | Q1 2025 · Mar 30, 2025 | $2.92B |
| Total Liabilities | Q1 2025 · Dec 29, 2024 | $3.25B |
| Current Assets | Q1 2025 · Mar 30, 2025 | $318.88M |
| Current Assets | Q1 2025 · Dec 29, 2024 | $320.52M |
| Total Assets | Q1 2025 · Mar 30, 2025 | $3.31B |
| Total Assets | Q1 2025 · Dec 29, 2024 | $3.38B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 87.02M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $21.08M |
| Capex restated | Q1 2025 · Mar 31, 2024 | $53.77M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $73.79M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.96 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.96 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $59.48M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$83.87M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $70.92M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $315.52M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $1.07B |